Codexis: Stewart Parker

Codexis announced the appointment of Stewart Parker to its board of directors. Parker previously served as CEO of the Infectious Disease Research Institute. Prior to that, she was CEO of Targeted Genetics. Parker has also served on the boards of IMPEL Pharmaceuticals, StrideBio, Achieve Life Sciences, and the BIO trade organization. She holds an MBA in finance and international business from the University of Washington.